Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Earnings out 4/3/08 ?

<There will be no share buy-backs happening until after the 10Q, nor an acquisition. >

From the Jan 29th BOD ltr to sharholders:

<The Company is currently unable to repurchase Patriot shares in the market at this time due to the same blackout period that currently prevents insiders from stock transactions>

Now how does one explain the Flowers response to Bluewing?:

<He would not give me a direct answer as to whether stock buybacks were taking place. He kept mentioning the SEC rules and the fact that he would not comment directly on how they had interpreted the rules. I mentioned the PR released stating that company officers could not buy back shares. He commented that the PR content wording was too general. >

If the company can't, why give such a reply? He was not aware of what the BOD letter to shareholders said on this exact point? Look forward to your thinking on this. Opty

Share
New Message
Please login to post a reply